Global Neuroprosthetics Market Size By Technique, By Source, By Application, By Geographic Scope And Forecast

Neuroprosthetics Market Valuation - 2024-2031

Increasing incidences of neurological disorders among the demographic population, especially the aged group, is intensifying the demand for bioengineered technologies, including neuroprosthetics, creating significant growth opportunities for the market. As per the Verified Market Research (VMR) analyst, amalgamation between sophisticated technologies and unmet neurological disorders or injuries is estimated to support the Neuroprosthetics Market to reach a valuation of USD 28.11 Billion over the forecast 2031, overshadowing the revenue of USD 11.27 Billion valued in 2023.

Moreover, the rising application of personalized brain-computer interfaces for the rehabilitation of individuals having brain dysfunction or disorders is enabling the market to grow at a CAGR of 12.11% from 2024 to 2031.

Global Neuroprosthetics Market: Definition/ Overview

Neuroprosthetics is a field of science and engineering that focuses on developing devices to replace or enhance the function of the nervous system. In simpler terms, it's about creating artificial tools that can interact with our brains or nerves to help people with disabilities or medical conditions. Its applications include assisting people with disabilities in regaining control of mechanical limbs to treating neurological illnesses through modification of brain activity, demonstrating the potential to dramatically improve the quality of life for those facing varied problems.

Furthermore, neuroprosthetics has demonstrated potential in the restoration of sensory functions. One kind of neuroprosthetic device that aids people with hearing loss is a cochlear implant. By stimulating the auditory nerve directly, these implants avoid damaging the ear's internal components and enable hearing.

What will the Integration of AI do to the Neuroprosthetics Market?

Penetration of artificial intelligence, machine learning, and the internet in the medical field has led to the development of miniaturized, portable, sophisticated, and efficient biotechnologies such as neuroprosthetics. Such technical breakthroughs are enabling the market to grow at a rapid pace over the forecast period.

An increase in the prevalence of neurological disorders or injuries such as Alzheimer's disease, Parkinson's disease, brain stroke, and spinal cord damage among the aging population is driving the demand for innovative neuroprosthetic solutions. With the rise in the application of brain-computer interfaces and deep brain simulations, the restoration of motor control through seamless communication between the device and the brain is gaining momentum.

In addition to this, rising demand for higher efficiency, less pain, and faster recovery is enhancing the demand for biocompatible and tiny implants, creating new avenues of growth for the current market. Furthermore, government programs favoring and investing in research and development of neuroprosthetics in compliance with stringent regulations are improving public awareness regarding the benefits of this technology. Thus, neuroprosthetics is potentially gaining worldwide acceptance as a suitable treatment option responsible for improving the quality of life of millions of people.

How will the Competitive Costing Clubbed with Regulatory Constrains Restrain the Growth of the Neuroprosthetics Market?

The time-consuming developmental procedures owing to the technical complexities of the minutest of structures used in neuroprosthetic devices are inhibiting its application. In addition to this, the extensive period required for the regulatory approval of these devices will further challenge the growth of the neuroprosthetic market. All these factors add up to the cost, thereby avoiding its adoption in budget-constrained healthcare facilities or patients.

Also, the unfavorable This restricts the potential influence of neuroprosthetic technology on a larger population by impeding their greater adoption and accessibility.

Increasing ethical concerns associated with the implantation of this technology owing to its potential risks such as personal data theft, and social inequality surrounding equitable access, in the future will majorly impact its application in the coming years.

If the complexity of human brain anatomy are to be considered, the stringent regulations and ethical concerns regarding data safety and communicative standards are to be majorly prioritized, creating a barrier for the growth of this market.

Category-Wise Acumens

How can Technical Innovations Shape the Growth Prospects of Spinal Cord Stimulation Segment?

The Spinal Cord Stimulation segment is estimated to hold the major share in the global Neuroprosthetics Market during the forecast period.

Increasing prevalence of spine related injuries due to external trauma, such as accidents, fall, and others, are spurring the demand for spinal cord simulation technologies. At the same time, the integration of programmable simulation parameters, miniaturized solutions, rechargeable batteries for convenience and patient comfort will further bolster the adoption of this technology.

With the rising technical advancements, the ability of spinal cord simulations to enable reducing chronic pain related to back, neck, and complex regional pain syndrome is letting this segment retain its dominance.

Will High Prevalence of Motor Neuron Disorders Skyrocket the Sales of Neuroprosthetics?

As per the research analyst, the motor neuron disorders segment is estimated to dominate the Neuroprosthetics Market during the forecast period.

An increase in the prevalence of conditions like Parkinson's disease, epilepsy, and spinal cord injury among the demographic populace is driving the demand for improved diagnostic technologies, thereby creating a substantial demand for motor neuron disorders-related solutions.

Additionally, the expanding coverage by insurance and government reimbursement programs for specific neuroprosthetic devices serves as a significant catalyst is further supporting market growth. This situation creates a compelling incentive for both patients and healthcare providers, thereby offering a chance to explore emerging neuroprosthetic solutions despite the existing limitations.

By addressing the increasing cases of motor neuron related damages and favorable healthcare policies, it is likely that the motor neuron disorders will continue holding a major share in the global market till 2031.

Country/Region-wise Acumens

How will the Sales of Neural Interface Technologies Play for Neuroprosthetics Market in North America?

According to VMR analysts, North America is estimated to dominate the Neuroprosthetics Market during the forecast period owing to the emergence of well-equipped medical infrastructure to improve the quality of treatment procedures for the highly prevalent neurological disorders. Additionally, government support and funding for research and development of neurology-related technologies is anticipated to improve the quality of life of the paralyzed or chronic neurological ailment patients from this region.

The switch towards a sedentary lifestyle and socializing activities such as smoking and alcohol consumption are increasing the cases of accidents and neurological disorders. Thus, propelling the demand for innovative neural interface technologies among Americans.

Furthermore, the development of hi-end neuroprosthetic technologies such as neuralink is projected to exhibit the importance of modern healthcare solutions in this region. Thus, breakthrough like this is allowing the market gain momentum over the forecast period.

Will Growing Geriatric Population turn Asia Pacific the Epicenter of growth for the Neuroprosthetics Market?

Asia Pacific is estimated to exhibit significant growth in the Neuroprosthetics Market during the forecast period. This growth is attributable to the presence of large volume of aging population susceptible to neurological disorders or injuries in the heavily populated countries such as China and India.

Rapid modernization in the region is propelling the adoption of western culture such as smoking, drug abuse, and drinking, resulting in accidents. These socializing activities are likely to increase the incidences of neurological ailments, thereby fostering the growth of Neuroprosthetics Market.

Meanwhile, the focus of the government on making these technologies accessible to all in alignment with the stringent regulatory norms are playing a crucial role in enhancing the implementation of neuroprosthetics in this region.

Beyond all these factors, the rising disposable income is increasing the ability of patients to invest in healthcare and medical interventions, thereby stirring up the consumer base for neuroprosthetic products and services.

The presence of prominent players such as Medtronic, Abbott, Boston Scientific, St Jude Medical, and Cochlear in the region is projected to drive the Neuroprosthetics Market.

Global Neuroprosthetics Market: Segmentation Analysis

The Global Neuroprosthetics Market is Segmented on the basis of Technique, Source, Application, And Geography.

Neuroprosthetics Market, By Technique

• Spinal Cord Stimulation
• Deep Brain Stimulation
• Vagus Nerve Stimulation
• Sacral Nerve Stimulation
• Transcranial Magnetic Stimulation

Based on Technique, The market is bifurcated into Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Transcranial Magnetic Stimulation. The Spinal Cord Stimulation (SCS) segment held the largest share owing to the analgesic property of the SCS therapy used in the treatment of ischemic pain, failed back surgery syndrome, and complex refractory pain syndrome. Moreover, it gains applications in intraspinal and epidural microstimulation for persuading leg movements.

Neuroprosthetics Market, By Source

• Output Neural Prosthetics
• Input Neural Prosthetics

Based on Source, The market is bifurcated into Output Neural Prosthetics and Input Neural Prosthetics. The Output Neural Prosthetics segment is accounted to hold the largest market size by volume.

Neuroprosthetics Market, By Application

• Motor Neuron Disorders
• Physiological Disorders
• Cognitive Disorders

Based on Application, The market is bifurcated into Motor Neuron Disorders, Physiological Disorders, and Cognitive Disorders. Motor neuron disorders held the largest segment due to the rising incidences of Parkinson's disease and epilepsy.

Neuroprosthetics Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Regional Analysis, The Global Neuroprosthetics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The Asia Pacific is anticipated to be the fastest-growing segment due to the introduction of multinational healthcare establishments promoting safe and effective medical procedures along with the rising awareness levels amongst consumers.

Key Players

The "Global Neuroprosthetics Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as Boston Scientific Corporation, Cochlear Limited, Medtronic, Inc., Cyberonics, Inc., NDI Medical LLC, NeuroPace, Inc., Nervo Corp., Retina Implant AG, St. Jude Medical, Sonova Group, Abbott, Stryker, Second Sight Medical Products, Paralytics, NeuroSky, Ctrl-Labs, BrainCo, Synchron, NextMind, Neurable, Blackflin, Cyberdyne, ReWalk Robotics, Ekso Bionics, BrainChip, Kernel, and Intuit Health.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In December 2023, Abbott received FDA approval for its Intellineura DBS device, the first completely implantable deep brain stimulation (DBS) device for treating movement disorders such as Parkinson's disease, essential tremor, and dystonia. With the removal of the external battery pack requirement, this minimally invasive technology may increase patient comfort and lower the risk of infection.
• In December 2023, Medtronic presented encouraging preliminary results from its current clinical trial for its RestoreSensor SCS System. To enhance pain management and quality of life for individuals with chronic pain, this innovative device combines conventional spinal cord stimulation with sensory perception restoration.
• In November 2023, Stryker and Synchron announced a strategic partnership to accelerate the development and commercialization of brain-computer interfaces. This collaboration combines Stryker's expertise in neurosurgical devices with Synchron's Stentrode technology, a minimally invasive BCI implant.